semaglutide risk of cancer Does cause cancer? An evidence-based guide Drugs like Ozempic and Wegovy

However, whether it is harmful or beneficial for subjects with mild cardiovascular diseases or even those without clinical manifestations is still controversial, likely because of the following reasons: (i) similar strains of mice in different studies from different suppliers differ in baseline bacterial gut microbiome, diet (e.g., different choline levels), age of the mice, animal housing conditions, and duration of the experiment

Pantoliano, M

Clinical trial data from the SURMOUNT programme consistently shows greater weight loss with tirzepatide than with semaglutide at comparable doses, which is why Mounjaro has become the more commonly prescribed option for women starting GLP-1 treatment in the UK through private providers like SheMed

This is not required for safety but smooths the transition